CAFFEINE CITRATE INJECTION USP DIN 02526778
Status: Marketed
Holder: OMEGA LABORATORIES LIMITED
Available to quote
Health Canada record
| Active ingredient(s) | CAFFEINE CITRATE 20 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N06BC01 CAFFEINE |
|---|
| Original market date | 11-Jul-2023 |
|---|
| Current status date | 11-Jul-2023 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — licence 100277, not currently licensed, last inspection rating C (2025-05-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CAFFEINE CITRATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02526751 | CAFFEINE CITRATE ORAL SOLUTION USP | OMEGA LABORATORIES LIMITED | Solution | CAFFEINE CITRATE 20 MG | Marketed |
| 02496771 | PEYONA | CHIESI FARMACEUTICI S.P.A. | Solution | CAFFEINE CITRATE 20 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 28021 | 2022-04-25 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for CAFFEINE CITRATE INJECTION USP
How to read a Canadian DIN record